Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28,694,438
-
Total 13F shares
-
512,251
-
Share change
-
-23,400
-
Total reported value
-
$132,483
-
Price per share
-
$0.26
-
Number of holders
-
17
-
Value change
-
-$26,697
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q1 2025
As of 31 Mar 2025,
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
512,251 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Sheaff Brock Investment Advisors, LLC, CAPTRUST FINANCIAL ADVISORS, Warberg Asset Management LLC, HRT FINANCIAL LP, STATE STREET CORP, Van Hulzen Asset Management, LLC, IFP Advisors, Inc, and NORTHERN TRUST CORP.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.